Glenmark Pharmaceuticals gains on getting USFDA’s approval for Clindamycin Phosphate Foam
Glenmark Pharmaceuticals is currently trading at Rs. 505.00, up by 10.05 points or 2.03% from its previous closing of Rs. 494.95 on the BSE. The scrip opened at Rs. 491.25 and has touched a high and low of Rs. 506.65 and Rs. 489.10 respectively. So far 94808 shares were traded on the counter. The BSE … Read more



